Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Stone, Misty Uhlfelder, A. Moore, G. Hoffman, J. Holbrook, C. Meinert, J. Donithan, N. Min, L. Murrow, M. Oziemkowska, A. Tibbs, J. Tonascia, M. Natta, Joseph Mccune, B. Coomer, B. Gilson, H. Haftel, F. Martinez, N. Rose, C. Burek, J. Barin, M. Talor, P. Canner, D. Conn, J. Klippel, Landis, B. White, R. Luqmani, Grp Wgetr. (2002)
Design of the Wegener's Granulomatosis Etanercept Trial (WGET).Controlled clinical trials, 23 4
L. Shand, M. Lunt, S. Nihtyanova, M. Hoseini, A. Silman, C. Black, C. Denton (2007)
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model.Arthritis and rheumatism, 56 7
Joseph III1, Mark Wurfel3, Kevin Flaherty1, Eric White1, Fernando Martinez1, William Travis2, Ganesh Raghu3 (2001)
Usual Interstitial PneumoniaSEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE,, 22
S. Antoniu (2007)
Cyclophosphamide for scleroderma interstitial lung diseaseExpert Opinion on Investigational Drugs, 16
F. Arnett, Mimi Cho, S. Chatterjee, Martha Aguilar, J. Reveille, Maureen Mayes (2001)
Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts.Arthritis and rheumatism, 44 6
V. Steen, Medsger Ta (1997)
The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis.Arthritis and rheumatism, 40 6
Sacks Dg, Y. Okano, V. Steen, E. Curtiss, L. Shapiro, T. Medsger (1996)
Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.The Journal of rheumatology, 23 4
R. Hoyles, R. Ellis, Jessica Wellsbury, B. Lees, P. Newlands, N. Goh, C. Roberts, S. Desai, A. Herrick, N. McHugh, N. Foley, S. Pearson, P. Emery, D. Veale, C. Denton, A. Wells, C. Black, R. Bois (2006)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.Arthritis and rheumatism, 54 12
C. Salliot, L. Mouthon, M. Ardizzone, J. Sibilia, L. Guillevin, J. Gottenberg, X. Mariette (2006)
Sjogren's syndrome is associated with and not secondary to systemic sclerosis.Rheumatology, 46 2
R. Silver, K. Miller, Margaret Kinsella, E. Smith, S. Schabel (1990)
Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.The American journal of medicine, 88 5
V. Steen, T. Medsger (1997)
The palpable tendon friction rubArthritis & Rheumatism, 40
Daniel Furst, P. Clements, Marwan Saab, And STERZ, Harold Paulus (1984)
Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration.Annals of the Rheumatic Diseases, 43
I. Marie (2002)
Atteinte digestive au cours de la sclérodermie systémiqueRevue de Médecine Interne, 23
J. Pope, Shum Dt, R. Gottschalk, A. Stevens, R. Mcmanus (1996)
Increased pigmentation in scleroderma.The Journal of rheumatology, 23 11
V. Steen, G. Ziegler, G. Rodnan, T. Medsger (1984)
Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.Arthritis and rheumatism, 27 2
S. Mathai, L. Hummers, H. Champion, F. Wigley, A. Zaiman, P. Hassoun, R. Girgis (2009)
Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.Arthritis and rheumatism, 60 2
Barbara White, Wendy Moore, Fredrick Wigley, Huiqing Xiao, R. Wise (2000)
Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and AlveolitisAnnals of Internal Medicine, 132
V. Steen, C. Conte, G. Owens, T. Medsger (1994)
Severe restrictive lung disease in systemic sclerosis.Arthritis and rheumatism, 37 9
M. Hudson, B. Thombs, R. Steele, P. Panopalis, Evan Newton, M. Baron (2009)
Quality of Life in Patients with Systemic Sclerosis Compared to the General Population and Patients with Other Chronic ConditionsThe Journal of Rheumatology, 36
J. Lynch, R. Saggar, S. Weigt, D. Ross, J. Belperio (2006)
Overview of lung transplantation and criteria for selection of candidates.Seminars in respiratory and critical care medicine, 27 5
V. Steen (2003)
Scleroderma renal crisis.Rheumatic diseases clinics of North America, 29 2
K. Calamia, J. Scolapio, T. Viggiano (2000)
Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis.Clinical and experimental rheumatology, 18 5
D. Tashkin, R. Elashoff, Philip Clements, Michael Roth, Daniel Furst, Richard Silver, Jonathan Goldin, E. Arriola, Charlie Strange, M. Bolster, James Seibold, David Riley, V. Hsu, John Varga, Dean Schraufnagel, Arthur Theodore, Robert Simms, Robert Wise, Fredrick Wigley, Barbara White, Virginia Steen, Charles Read, M. Mayes, Ed Parsley, Kamal Mubarak, M. Connolly, Jeffrey Golden, Mitchell Olman, B. Fessler, Naomi Rothfield, M. Metersky, Dinesh Khanna, Ning Li, Gang Li (2007)
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.American journal of respiratory and critical care medicine, 176 10
G. Shibukawa, A. Irisawa, Natsumi Sakamoto, T. Takagi, T. Wakatsuki, H. Imamura, Yuta Takahashi, Ai Sato, Masaki Sato, T. Hikichi, K. Obara, H. Ohira (2007)
Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis: relapse after endoscopic treatment by argon plasma coagulation.Internal medicine, 46 6
J. King, U. Costabel, J. Cordier, G. Dopico, R. Dubois, D. Lynch, J. Lynch, J. Myers, R. Panos, G. Raghu, D. Schwartz, C. Smith (2000)
Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus StatementAmerican Journal of Respiratory and Critical Care Medicine, 161
J. Pope (2003)
Musculoskeletal involvement in scleroderma.Rheumatic diseases clinics of North America, 29 2
S. Arcasoy, J. Christie, V. Ferrari, M. Sutton, D. Zisman, N. Blumenthal, A. Pochettino, R. Kotloff (2003)
Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.American journal of respiratory and critical care medicine, 167 5
P. Merkel, K. Herlyn, Richard Martin, Jennifer Anderson, M. Mayes, P. Bell, J. Korn, R. Simms, M. Csuka, T. Medsger, N. Rothfield, M. Ellman, D. Collier, A. Weinstein, D. Furst, S. Jimenez, B. White, J. Seibold, F. Wigley (2002)
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.Arthritis and rheumatism, 46 9
M. Kuwana, J. Kaburaki, Y. Okano, T. Tojo, M. Homma (1994)
Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.Arthritis and rheumatism, 37 1
P. Clements, P. Lachenbruch, D. Furst, H. Paulus (1993)
The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo.Arthritis and rheumatism, 36 11
D. Khanna, D. Furst, P. Clements, D. Tashkin, M. Eckman (2008)
Oral Cyclophosphamide for Active Scleroderma Lung Disease: A Decision AnalysisMedical Decision Making, 28
D. Tashkin, R. Elashoff, P. Clements, J. Goldin, Michael Roth, Daniel Furst, E. Arriola, R. Silver, C. Strange, M. Bolster, J. Seibold, David Riley, V. Hsu, J. Varga, Dean Schraufnagel, A. Theodore, R. Simms, R. Wise, F. Wigley, B. White, V. Steen, C. Read, M. Mayes, E. Parsley, K. Mubarak, M. Connolly, J. Golden, M. Olman, B. Fessler, N. Rothfield, M. Metersky (2006)
Cyclophosphamide versus placebo in scleroderma lung disease.The New England journal of medicine, 354 25
V. Steen (1996)
Autoantibodies in systemic sclerosis.Seminars in arthritis and rheumatism, 35 1
M. Nikpour, W. Stevens, A. Herrick, S. Proudman (2010)
Epidemiology of systemic sclerosis.Best practice & research. Clinical rheumatology, 24 6
N. Goh, S. Veeraraghavan, S. Desai, D. Cramer, D. Hansell, C. Denton, C. Black, R. Bois, A. Wells (2007)
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.Arthritis and rheumatism, 56 6
V. Steen, T. Medsger (1997)
The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time.Arthritis and rheumatism, 40 11
H. Penn, A. Howie, E. Kingdon, C. Bunn, R. Stratton, C. Black, A. Burns, C. Denton (2007)
Scleroderma renal crisis: patient characteristics and long-term outcomes.QJM : monthly journal of the Association of Physicians, 100 8
(2002)
Guidelines for the six-minute walk test
I. Marie, St�phane Dominique, H. Lévesque, Philippe Ducrott�, P. Denis, M. Hellot, H. Courtois (2001)
Esophageal involvement and pulmonary manifestations in systemic sclerosis.Arthritis and rheumatism, 45 4
L. Czirják, I. Foeldvari, U. Müller-Ladner (2008)
Skin involvement in systemic sclerosis.Rheumatology, 47 Suppl 5
J. Pope, Peter Lee, M. Baron, J. Dunne, Douglas Smith, P. Docherty, A. Bookman, M. Abu-Hakima (2005)
Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis.The Journal of rheumatology, 32 7
N. Oliveira, L. Sabbag, LM Ueno, R. Souza, C. Borges, A. Pinto, F. Lima (2007)
Reduced exercise capacity in systemic sclerosis patients without pulmonary involvementScandinavian Journal of Rheumatology, 36
J. Stone (2005)
Etanercept plus Standard Therapy for Wegener's Granulomatosis
U. Walker, A. Tyndall, L. Czirják, C. Denton, D. Farge-Bancel, O. Kowal-Bielecka, U. Müller-Ladner, C. Bocelli-Tyndall, M. Matucci-Cerinic (2007)
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group databaseAnnals of the Rheumatic Diseases, 66
S. Plastiras, S. Karadimitrakis, P. Ziakas, P. Vlachoyiannopoulos, H. Moutsopoulos, G. Tzelepis (2006)
Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.Arthritis and rheumatism, 55 4
L. Teixeira, A. Mahr, A. Bérézné, L. Noël, L. Guillevin, L. Mouthon (2007)
Scleroderma Renal Crisis, Still a Life‐Threatening ComplicationAnnals of the New York Academy of Sciences, 1108
J. Poole, C. Williams, D. Bloch, B. Hollak, P. Spitz (1995)
Concurrent validity of the Health Assessment Questionnaire Disability Index in Scleroderma.Arthritis care and research : the official journal of the Arthritis Health Professions Association, 8 3
A. Herrick (2005)
Pathogenesis of Raynaud's phenomenon.Rheumatology, 44 5
A. Thompson, B. Shea, V. Welch, D. Fenlon, J. Pope (2001)
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis.Arthritis and rheumatism, 44 8
Jürgen Behr, Claus Vogelmeier, T. Beinert, Michael Meurer, Fritz Krombach, G. König, G. Fruhmann (1996)
Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.American journal of respiratory and critical care medicine, 154 2 Pt 1
E. Rhew, W. Barr (2004)
Scleroderma renal crisis: New insights and developmentsCurrent Rheumatology Reports, 6
C. Rigamonti, L. Shand, M. Feudjo, C. Bunn, C. Black, C. Denton, A. Burroughs (2005)
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosisGut, 55
J. Pope (2002)
Scleroderma overlap syndromes.Current opinion in rheumatology, 14 6
C. Strange, M. Bolster, M. Roth, R. Silver, A. Theodore, J. Goldin, P. Clements, J. Chung, R. Elashoff, R. Suh, Edwin Smith, D. Furst, D. Tashkin (2008)
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease.American journal of respiratory and critical care medicine, 177 1
Masataka Kuwana, Carol Feghali, Thomas Medsger, Timothy Wright (2001)
Autoreactive T cells to topoisomerase I in monozygotic twins discordant for systemic sclerosis.Arthritis and rheumatism, 44 7
M. Luggen, L. Belhorn, T. Evans, Oliver FitzGerald, George Spencer-Green (1995)
The evolution of Raynaud's phenomenon: a longterm prospective study.The Journal of rheumatology, 22 12
M. Meli, G. Gitzelmann, R. Koppensteiner, B. Amann-Vesti (2006)
Predictive value of naitfold capillaroscopy in patients with Raynaud’s phenomenonClinical Rheumatology, 25
V. Steen (2005)
Advancements in diagnosis of pulmonary arterial hypertension in scleroderma.Arthritis and rheumatism, 52 12
V. Steen, T. Medsger (2000)
Severe organ involvement in systemic sclerosis with diffuse scleroderma.Arthritis and rheumatism, 43 11
A. Thompson, J. Pope (1998)
A study of the frequency of pericardial and pleural effusions in scleroderma.British journal of rheumatology, 37 12
J. Pope (2011)
Raynaud's phenomenon (primary).BMJ clinical evidence, 2011
V. Steen, M. Lucas, N. Fertig, T. Medsger (2007)
Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.The Journal of rheumatology, 34 11
M. Hirschl, Katharina Hirschl, M. Lenz, R. Katzenschlager, H. Hutter, M. Kundi (2006)
Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance.Arthritis and rheumatism, 54 6
S. Lori, M. Matucci-Cerinic, Roberto Casale, S. Generini, A. Lombardi, A. Pignone, C. Scaletti, P. Gangemi, M. Cagnoni (1996)
Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structure.Clinical and experimental rheumatology, 14 6
S. Pavlov-Dolijanovic, N. Damjanov, P. Ostojic, G. Sušić, R. Stojanovic, D. Gacic, A. Grdinić (2006)
The Prognostic Value of Nailfold Capillary Changes for the Development of Connective Tissue Disease in Children and Adolescents with Primary Raynaud Phenomenon: A Follow‐up Study of 250 PatientsPediatric Dermatology, 23
Firas Al-Dhaher, J. Pope, J. Ouimet (2010)
Determinants of morbidity and mortality of systemic sclerosis in Canada.Seminars in arthritis and rheumatism, 39 4
Sergio Morelli, Luigi Ferrante, A. Sgreccia, Maria Eleuteri, C. Perrone, P. Marzio, F. Balsano (2000)
Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosisScandinavian Journal of Rheumatology, 29
E. Ebert (2006)
Esophageal disease in scleroderma.Journal of clinical gastroenterology, 40 9
H. Claman, H. Claman, R. Giorno, R. Giorno, J. Seibold (2010)
Endothelial and fibroblastic activation in scleroderma. The myth of the "uninvolved skin".Arthritis and rheumatism, 34 12
R. Clements, A. Simanowitz (2000)
international consensus statement
M. Cutolo, C. Pizzorni, M. Tuccio, A. Burroni, C. Craviotto, M. Basso, B. Seriolo, A. Sulli (2004)
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.Rheumatology, 43 6
V. Steen, T. Medsger (2000)
Long-Term Outcomes of Scleroderma Renal CrisisAnnals of Internal Medicine, 133
J. Pope, A. Thompson (1999)
Antimitochondrial antibodies and their significance in diffuse and limited scleroderma.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 5 4
J. Pope, J. Al-Bishri, Hafsah Al-Azem, J. Ouimet (2008)
The Temporal Relationship of Raynaud’s Phenomenon and Features of Connective Tissue Disease in Rheumatoid ArthritisThe Journal of Rheumatology, 35
A. Perera, N. Fertig, M. Lucas, T. Rodríguez-Reyna, P. Hu, V. Steen, T. Medsger (2007)
Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.Arthritis and rheumatism, 56 8
J. Pope (2005)
Other manifestations of mixed connective tissue disease.Rheumatic diseases clinics of North America, 31 3
G. Lock, A. Holstege, B. Lang, J. Schölmerich (1997)
Gastrointestinal manifestations of progressive systemic sclerosis.The American journal of gastroenterology, 92 5
C. Witt, A. Borges, M. John, I. Fietze, G. Baumann, A. Krause (1999)
Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitisAnnals of the Rheumatic Diseases, 58
[Systemic sclerosis (scleroderma; SSc) is a chronic con nective tissue disease characterized by inflammation within, and fibrosis of, the skin, vascular abnormalities, visceral damage, and the production of autoantibodies. SSc is divided generally into limited and diffuse forms, based on the extent of skin involvement. A group of conditions known as “localized” sclero-derma, which includes morphea, linear scleroderma, and en coup de sabre, is discussed in the chapter on Scleroderma Mimickers (Chap. 11). Diffuse SSc has a greater extent of skin involvement and is more likely to be associated with renal crisis, pulmonary fibrosis, and cardiomyopathy. Patients with diffuse SSc have a higher mortality rate. Pulmonary disease remains a major source of morbidity and mortality for patients with SSc. Patients with limited SSc are predisposed to the development of pulmonary arterial hypertension (PAH). Those with diffuse SSc are predisposed to interstitial fibrosis. Autoantibody profiles can predict to a certain extent the types of organ involvement that can be expected in SSc. Raynaud's phenomenon (RP) is characterized by vasospasm of the digital arteries that leads to well-demarcated pallor with cyanosis and rubor. RP is essentially universal among patients with SSc and is the first symptom in a large majority of patients. Primary RP is often mild enough not to require treatment; however, with secondary RP from SSc, there is not only vasospasm but also fixed blood vessel problems with luminal narrowing, so the ischemia can be more severe. Complications of RP in SSc can include digital ulcers often leading to infection and amputation causing pain and functional disability. Diffuse SSc often presents with puffiness of the hands associated with pain, in a way that can mimic rheumatoid arthritis. RP often occurs around the time of development of puffy hands in diffuse SSc.]
Published: Jan 1, 2009
Keywords: Pulmonary Arterial Hypertension; Primary Biliary Cirrhosis; Interstitial Lung Disease; Forced Vital Capacity; Health Assessment Questionnaire Disability Index
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.